Overview
68Ga-FAPI-04 PET/CT for the Detection of Oral Carcinoma
Status:
Recruiting
Recruiting
Trial end date:
2022-07-01
2022-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
FAPI is a fibroblast activation protein inhibitor and 68Ga-FAPI-04 is a potential new imaging agent for imaging of carcinoma. 68Ga-FAPI-04 PET/CT is helpful to clarify the benign, malignant and invasive range of the oral carcinoma, locate and qualitatively diagnose the tumor, and make early diagnosis and restaging of recurrent tumor.Phase:
Early Phase 1Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Peking Union Medical College Hospital
Criteria
Inclusion Criteria:- patients in suspicion of oral carcinoma,and being able to provide basic information
and sign the written informed consent form.
Exclusion Criteria:
- The exclusion criteria included claustrophobia, pregnancy, breastfeeding, kidney or
liver failure, inability to fulfill the study.